Chemed Corp: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Jul 31, 2020 and accepted by EDGAR at Jul 31, 2020, 09:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-04-01 to 2020-06-30 | $502.2m | us-gaap:Revenues |
| Revenue | 6 months2020-01-01 to 2020-06-30 | $1.02bn | us-gaap:Revenues |
| Cost of revenue | 3 months2020-04-01 to 2020-06-30 | $352.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2020-01-01 to 2020-06-30 | $703.9m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2020-04-01 to 2020-06-30 | $84.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-01-01 to 2020-06-30 | $155.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-04-01 to 2020-06-30 | $92.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-01-01 to 2020-06-30 | $172.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-04-01 to 2020-06-30 | $651.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2020-01-01 to 2020-06-30 | $1.6m | us-gaap:InterestExpense |
| Income tax | 3 months2020-04-01 to 2020-06-30 | $17.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-01-01 to 2020-06-30 | $30.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-04-01 to 2020-06-30 | $82.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-01-01 to 2020-06-30 | $138.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | $5.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-01-01 to 2020-06-30 | $8.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-04-01 to 2020-06-30 | $5.16 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-01-01 to 2020-06-30 | $8.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-04-01 to 2020-06-30 | 16,373,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-01-01 to 2020-06-30 | 16,445,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-01-01 to 2020-06-30 | $277.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-01-01 to 2020-06-30 | $32.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2020-01-01 to 2020-06-30 | $10.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2020-01-01 to 2020-06-30 | $122.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-06-30 | $20.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-06-30 | $189.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $1.29bn | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $318.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $540.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-06-30 | $750.7m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2020-06-30 | 15,919,194 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000019584-20-000033. Last ingested by Listed: Nov 5, 2026, 15:55 ET. Listed shows no prices and gives no investment advice.